Home > PS Ratio > MARKSANS PHARMA

MARKSANS PHARMA
PS (Price/Sales) Ratio

The Current P/S Ratio of MARKSANS PHARMA is 3.72.

Share Price ₹215.6Aug 06,2025
Market Cap ₹9,768.7 Cr
Sales-TTM₹2,622.8 CrTTM-Consolidated Results
Price/Sales3.72xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals

Definition & Calculation of PS (Price/Sales) ratio of MARKSANS PHARMA

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of MARKSANS PHARMA is calculated as :

Current Market Cap [ ₹9,768.7 Cr] as on Aug 06,2025

(/) Sales [ ₹2,622.8 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 3.72x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for MARKSANS PHARMA , the investors are currently willing to pay '3.72 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of MARKSANS PHARMA !

The chart below summarizes the trend in P/S Ratio of MARKSANS PHARMA over the last five years.

Historical PS (Price/Sales) ratio chart of MARKSANS PHARMA


PS Ratio Performance Analysis for MARKSANS PHARMA

- MARKSANS PHARMA 's latest p/e ratio is 3.72x.

- MARKSANS PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 2.29x.

- MARKSANS PHARMA 's operated at median p/e ratio of 1.72x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, MARKSANS PHARMA 's p/e ratio peaked in Mar2025 at 3.84x.

- MARKSANS PHARMA 's p/e ratio hit its five-year low in Mar2022 of 1.25x.


How does MARKSANS PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
MARKSANS PHARMA 2,622.83.729,768.7
SUN PHARMACEUTICAL INDUSTRIES LTD53,777.17.11382,478.0
DIVIS LABORATORIES LTD9,652.016.87162,845.0
CIPLA LTD27,811.24.32120,121.0
TORRENT PHARMACEUTICALS LTD11,835.010.08119,327.0
DR REDDYS LABORATORIES LTD33,519.92.9899,907.8
MANKIND PHARMA LTD12,956.28.13105,380.0
ZYDUS LIFESCIENCES LTD23,241.54.0493,881.6
LUPIN LTD23,375.93.6284,571.3
AUROBINDO PHARMA LTD32,024.81.9562,308.4
ABBOTT INDIA LTD6,409.210.8169,302.6

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs MARKSANS PHARMA 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 1.95x
Max industry PS 16.87x
Median industry PS 4.32x
Average industry PS 6.69x



You may also like the below Video Courses